LSB — LakeShore Biopharma Co Balance Sheet
0.000.00%
Last trade - 00:00
- $92.26m
- $131.44m
- CNY687.20m
- 18
- 56
- 47
- 35
2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Cash | |||
Short Term Investments | |||
Cash and Short Term Investments | 392 | 274 | 374 |
Net Total Accounts Receivable | |||
Net Total Receivables | 248 | 313 | 468 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 733 | 765 | 1,036 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 253 | 565 | 583 |
Net Intangible Assets | |||
Other Long Term Assets | |||
Total Assets | 1,167 | 1,442 | 1,720 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 345 | 476 | 659 |
Long Term Debt | |||
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Liabilities | 391 | 771 | 991 |
Redeemable Preferred Stock | |||
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | 777 | 671 | 728 |
Total Liabilities & Shareholders' Equity | 1,167 | 1,442 | 1,720 |
Total Common Shares Outstanding |